Hematology/Oncology

Top Story

Majority of clinicians overestimate harms, benefits of treatment

August 29, 2016

Most resident and attending internal medicine physicians overestimated both the benefits and harms of common medical tests and treatments, according to findings published in JAMA Internal Medicine.

These included the prevention of myocardial infarction or stroke with daily aspirin, frequency of biopsy among patients receiving screening mammograms, prevention of hip fracture in patients with osteoporosis using alendronate and prevention of mortality in patients with acute peptic ulcer bleeding using proton pump inhibitors, Mona Krouss, MD, from the University of Maryland Medical Center, and colleagues reported.

In the Journals Plus

Early treatment shows long-term benefit for high-risk smoldering myeloma

August 29, 2016
Early treatment with lenalidomide plus dexamethasone prolonged time to progression and OS compared with observation for patients with high-risk smoldering multiple…

Extended work hours increase risk for cancer among U.S. women

August 29, 2016
Women in the United States who worked at least 60 hours per week during the span of 3 decades demonstrated increased risk for cancer and other chronic health problems…
In the Journals Plus

Timing between thyroidectomy, radioactive iodine does not affect DTC outcomes

August 29, 2016
Disease outcomes in differentiated thyroid cancer, or DTC, are not influenced by the time between total thyroidectomy and radioactive iodine dosing, study data show. …
In the Journals Plus

Longer continuous docetaxel treatment confers OS benefit in prostate cancer

August 29, 2016
A greater number of docetaxel cycles improved OS in men with metastatic castration-resistant prostate cancer, according to a post-hoc analysis of the phase 3 Mainsail…
More News Headlines »
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Video
At Issue

VIDEO: Immune checkpoint inhibitors show promise in metastatic, triple-negative breast cancer

August 9, 2016
More »
Featured
Discoveries from ASCO 2016: Breast Cancer

Discoveries from ASCO 2016: Breast Cancer

CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan